Patrick M. Dillon
Impact in
Papers in
- Oncology 34
- Cancer Treatment and Pharmacology 13
- Cancer Immunotherapy and Biomarkers 13
- HER2/EGFR in Cancer Research 6
-
- Advanced Breast Cancer Therapies 8
- Brain Metastases and Treatment 7
- Co-authors
- Christopher A. Moskaluk (3 shared papers)Christopher Y. Thomas (3 shared papers)Anne M. Mills (4 shared papers)Erik Dill (3 shared papers)Samhita Chakraborty (1 shared paper)Timothy N. J. Bullock (3 shared papers)Norman E. Sharpless (4 shared papers)Craig L. Slingluff (9 shared papers)
- Journals
- Journal of Clinical Oncology (13 papers)Medical Oncology (4 papers)Clinical Cancer Research (3 papers)The Oncologist (2 papers)Oncology (2 papers)
- Partner nations
- United StatesSpainSouth Korea
In The Last Decade
Patrick M. Dillon
80 papers receiving 2.2k citations
Patrick M. Dillon's Hit Papers
Peers
Comparison fields: 5 of 134
- Oncology 1.0k
- Aging 36
- Biological Psychiatry 45
- Immunology 362
- Cancer Research 200
Countries citing papers authored by Patrick M. Dillon
This map shows the geographic impact of Patrick M. Dillon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Patrick M. Dillon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Patrick M. Dillon more than expected).
Fields of papers citing papers by Patrick M. Dillon
This network shows the impact of papers produced by Patrick M. Dillon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Patrick M. Dillon. The network helps show where Patrick M. Dillon may publish in the future.
Co-authors
The 25 scholars most cited alongside Patrick M. Dillon, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 84 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Open-label Clinical Trial of Niraparib Combined With Pembrolizumab for Treatment of Advanced or Metastatic Triple-Negative Breast Cancer Hit paper breakdown → | 2019 | 331 |
| 2 | 2014 | 204 | |
| 3 | 2014 | 198 | |
| 4 | 2017 | 130 | |
| 5 | 2010 | 127 | |
| 6 | 2012 | 111 | |
| 7 | 2018 | 72 | |
| 8 | 2017 | 70 | |
| 9 | 2018 | 67 | |
| 10 | 2016 | 66 | |
| 11 | 2017 | 54 | |
| 12 | 2017 | 53 | |
| 13 | 2017 | 52 | |
| 14 | 2015 | 51 | |
| 15 | 2015 | 43 | |
| 16 | 2020 | 43 | |
| 17 | 1999 | 37 | |
| 18 | 2016 | 36 | |
| 19 | 2012 | 30 | |
| 20 | 2016 | 28 |
About Patrick M. Dillon
Patrick M. Dillon is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Molecular Biology, Radiology, Nuclear Medicine and Imaging and Surgery, having authored 84 papers that have together received 2.2k indexed citations. Recurring topics across this work include Cancer Treatment and Pharmacology (13 papers), Cancer Immunotherapy and Biomarkers (13 papers), Advanced Breast Cancer Therapies (8 papers), Brain Metastases and Treatment (7 papers), Monoclonal and Polyclonal Antibodies Research (6 papers), HER2/EGFR in Cancer Research (6 papers), Immunotherapy and Immune Responses (6 papers) and Salivary Gland Tumors Diagnosis and Treatment (5 papers). The work is most often cited by research in Oncology (1.0k citations), Aging (36 citations), Biological Psychiatry (45 citations), Immunology (362 citations) and Cancer Research (200 citations). Patrick M. Dillon has collaborated with scholars based in United States, Spain and South Korea. Frequent co-authors include Christopher A. Moskaluk, Christopher Y. Thomas, Anne M. Mills, Erik Dill, Samhita Chakraborty, Timothy N. J. Bullock, Norman E. Sharpless, Craig L. Slingluff, Chad Torrice and Hanna K. Sanoff. Their work appears in journals such as Journal of Clinical Oncology, Medical Oncology, Clinical Cancer Research, The Oncologist and Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.